Literature DB >> 7096435

Increased expression of SV40 T antigen and cell division in skin fibroblast cell lines derived from a family at high risk of carcinoma (family G of Warthin).

A S Lubiniecki, H T Lynch, W A Blattner, H Guirgis.   

Abstract

T-antigen expression in 24 of 31 skin fibroblast cell lines from members of Family G was found to be significantly elevated compared with a healthy control population. However, the pattern of elevation did not appear to be associated with cancer risk. In addition, T-antigen values were independent of the age and sex, as well as the branch of family and generation of the cell donor. Cell lines from Family G tended to divide more frequently than cell lines from control donors. This tendency was negatively associated with elevated T-antigen expression in Family-G cell lines, while control cell lines showed no such correlation. These results demonstrate that caution must be taken in evaluating potential markers of cancer risk. Superficial analysis of the data would indicate the utility of the T-antigen assay as a marker for cancer family syndrome. However, consideration of additional factors, including pedigree relationships and cell biology in vitro, indicate that SV40 T-antigen expression is an ambiguous marker of this type of cancer risk, even when large groups are studied.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7096435     DOI: 10.1007/BF00409643

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  10 in total

1.  An improved method of fixation for immunofluorescent detection of SV40 T-antigen in infected human fibroblasts.

Authors:  M M Kaplan; D J Giard; W A Blattner; A S Lubiniecki; J F Fraumeni
Journal:  Proc Soc Exp Biol Med       Date:  1975-03

2.  Elevated expression of T-antigen in simian papovavirus 40-infected skin fibroblasts from individuals with cytogenetic defects.

Authors:  A S Lubiniecki; W A Blattner; J F Fraumeni
Journal:  Cancer Res       Date:  1977-05       Impact factor: 12.701

3.  SV40 T-antigen expression in skin fibroblasts from clinically normal individuals and from ten cases of Fanconi anemia.

Authors:  A S Lubiniecki; W A Blattner; H Dosik; C Sun; J F Fraumeni
Journal:  Am J Hematol       Date:  1977       Impact factor: 10.047

4.  Genetics of SV40 T-antigen expression: studies of twins, heritable syndromes and cancer families.

Authors:  W A Blattner; A S Lubiniecki; J J Mulvihill; P Lalley; J F Fraumeni
Journal:  Int J Cancer       Date:  1978-09-15       Impact factor: 7.396

5.  Cancer family "G" revisited: 1895-1970.

Authors:  H T Lynch; A J Krush
Journal:  Cancer       Date:  1971-06       Impact factor: 6.860

6.  Familial leukaemia and SV40 transformation.

Authors:  E A McKeen; R W Miller; J J Mulvihill; W A Blattner; A S Levine
Journal:  Lancet       Date:  1977-08-06       Impact factor: 79.321

7.  SV40 T-antigen expression in acute non-lymphocytic leukaemia.

Authors:  A S Lubiniecki; W A Blattner; H Dosik; J F Fraumeni
Journal:  Br J Haematol       Date:  1979-12       Impact factor: 6.998

8.  Relationship of SV40 T-antigen expression in vitro to disorders of bone marrow function.

Authors:  A S Lubiniecki; W A Blattner; H Dosik; S McIntosh; W Wertelecki
Journal:  Am J Hematol       Date:  1980       Impact factor: 10.047

9.  Human skin fibroblasts from individuals genetically predisposed to cancer are sensitive to an SV40-induced T antigen display and transformation.

Authors:  L Kopelovich; S Sirlin
Journal:  Cancer       Date:  1980-03-15       Impact factor: 6.860

10.  Systematic variables affecting simian virus 40-induced T-antigen expression and transformation in human cells.

Authors:  M M Kaplan; A S Lubiniecki; W A Blattner; T Mason; D J Giard; M Gunnell; N Triantafellu; J F Fraumeni
Journal:  J Clin Microbiol       Date:  1976-06       Impact factor: 5.948

  10 in total
  1 in total

1.  Human polyomaviruses in skin diseases.

Authors:  Ugo Moens; Maria Ludvigsen; Marijke Van Ghelue
Journal:  Patholog Res Int       Date:  2011-09-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.